BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 8, 2019
View Archived Issues
Rb and CDK
Read More
Food dye is secret ingredient for tissue-feeding vasculature
Read More
New engineered oncolytic vaccina virus constructs show cancer-specific activity
Read More
Phase III ASCEND study of Calquence meets primary endpoint at interim analysis
Read More
Long-term treatment for wet AMD using a single dose of OXB-203 shows promise
Read More
Positive interim data presented for first cohort in Polish phase I/II study of annamycin in AML
Read More
European Commission grants conditional approval for lorlatinib in patients with ALK-positive NSCLC
Read More
Study links KIAA1217 gene to cervical segmentation defects
Read More
Waylivra receives conditional marketing authorization from the European Commission
Read More
Humanized cells allow efficient flu virus isolation and growth
Read More
FDA clears IND application for NNI-362
Read More
Lentiviral CYBB gene therapy relieves disease symptoms in an X-CGD infant
Read More
Dupixent receives European approval for severe asthma
Read More
Ocular Therapeutix presents preliminary first-in-human data for OTX-TIC implant
Read More
First-in-human data presented for IVMED-10 and IVMED-20 for post-cataract inflammation
Read More
Pilot study of L1-79 demonstrates trends towards improvement in male subjects with ASD
Read More
Merck & Co. patents LRKK2-mutant inhibitors
Read More
Japanese researchers present IDO1 and/or TDO inhibitors
Read More
Enterprise Therapeutics discloses SCNN1A blockers
Read More
Jubilant Biosys describes new PADI4 inhibitors
Read More
JS Innopharm patents IDO1 and/or TDO inhibitors
Read More
Durect reports preliminary data from phase IIa study of DUR-928 in alcoholic hepatitis
Read More
REGENXBIO offers new interim phase I/IIa data on RGX-314 in wet AMD
Read More
MaxCyte advances phase I trial of MCY-M11 in advanced ovarian cancer and peritoneal mesothelioma
Read More
Phase II trial of Nepafenac Evolute shows postoperative pain reduction after cataract surgery
Read More
Allakos reports promising data from phase I study of AK-002 in severe allergic conjunctivitis
Read More